Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Inc. buy BTIG Research

Start price
€39.84
04.11.25 / 50%
Target price
€73.86
04.11.26
Performance (%)
-20.18%
Price
€31.80
10:33
Summary
This prediction is currently active. The price of Hims & Hers Health Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.18%. This prediction currently runs until 04.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Hims & Hers Health Inc. -7.665%
iShares Core DAX® -4.848%
iShares Nasdaq 100 -2.900%
iShares Nikkei 225® -4.615%
iShares S&P 500 -2.507%

Comments by BTIG_Research for this prediction

In the thread Hims & Hers Health Inc. diskutieren
Prediction Buy
Perf. (%) -20.18%
Target price 73.857
Change
Ends at 04.11.26

Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Stopped prediction by BTIG_Research for Hims & Hers Health Inc.

buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€26.20
07.01.25
€33.66
07.01.26
22.18%
10:33